SCHEMBL4661267

SCHEMBL4661267

COc1ccccc1C(c1ccnc2ccccc12)C(C#N)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
FABP5 Q01469 1/20 0.39
POLB P06746 2/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALOX15 P16050 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
GCGR P47871 1/20 0.37
SRC P12931 1/20 0.36
TGFBR1 P36897 1/20 0.36
NTSR1 P30989 1/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 4/20 0.36
RAB9A P51151 2/20 0.36
MAPK1 P28482 2/20 0.36
GAA P10253 1/20 0.36
GAK O14976 1/20 0.36
RIPK2 O43353 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4660037 0.90 KDM4E (0.39) ACHEFABP5POLBL3MBTL1HTR2C
SCHEMBL4661263 0.86 AAK1 (0.37) ACHEFABP5HTR2CHTR2BGCGR
SCHEMBL6404486 0.82 KMT2A (0.46) FABP5POLBHTTNPSR1L3MBTL1
SCHEMBL4659897 0.82 KMT2A (0.46) FABP5POLBHTTNPSR1L3MBTL1
SCHEMBL4659895 0.82 KMT2A (0.46) FABP5POLBHTTNPSR1L3MBTL1
SCHEMBL4659913 0.76 ESR1 (0.42) ACHEFABP5POLBHTTNPSR1
SCHEMBL4660099 0.76 KMT2A (0.47) FABP5L3MBTL1KDM4EMAPK1GAA
SCHEMBL4661303 0.76 PDE4D (0.44) HTTKDM4EMAPTRAB9AGAA
SCHEMBL4661666 0.73 KMT2A (0.45) POLBHTTNPSR1ALOX15HTR2C
SCHEMBL4661464 0.73 ESR1 (0.42) ACHEPOLBL3MBTL1HTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620102-B1 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH CORP (US) 2008-12-24 EP disclosed
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use WYETH (US) 2007-12-27 US disclosed
EP-1620102-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS Wyeth (US) 2006-02-01 EP disclosed
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis WYETH (US) 2005-11-17 US disclosed
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use WYETH 2005-01-06 US disclosed
WO-2004099150-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH (US) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis NFKBIA, IKBKB, NFKB2 ACHE 4818/4885FABP5 645/4885POLB 2751/4885
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use HCAR2, PCCA, MCCC2 ACHE 3173/4885FABP5 343/4885POLB 2104/4885
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use HCAR2, PCCA, MCCC2 ACHE 3446/4885FABP5 260/4885POLB 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.